News

Affimed Moves to File for Insolvency Proceedings Amid Challenges

Affimed Moves to File for Insolvency Proceedings Amid Challenges

Affimed N.V. Files for Insolvency Proceedings

Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company, has taken a significant step by filing for insolvency proceedings at the local court in Mannheim, Germany. This decision stems from a series of challenges, particularly in securing the necessary funding to sustain its operations and the operations of its subsidiaries, Affimed GmbH and Affimed Inc.

Challenges in Securing Funding

The company has been actively exploring various strategic transactions with potential investors and partners in a bid to raise additional capital. Despite ongoing efforts, including discussions with different stakeholders, the company has not been able to successfully secure the funds required for its continued operation. This has raised serious concerns about its liquidity and ability to continue as a viable business.

Management's Determination

Given the current financial landscape, the management board has come to a critical conclusion regarding the company’s financial health. It has been determined that both Affimed N.V. and Affimed GmbH are experiencing overindebtedness, making it necessary for the companies to file for insolvency under German law. This situation poses significant uncertainties about the future of both entities.

Insolvency Filing Details

On May 13, 2025, the formal filing for the opening of insolvency proceedings was submitted. This filing covers both Affimed N.V. and Affimed GmbH, as the respective management teams have made these decisions based on the bleak financial outlook. As a result of these proceedings, there’s a possibility of the company’s common shares being suspended from trading, leading to a potential delisting from the Nasdaq Global Market.

Future Considerations

The glide path towards resolving the insolvency proceedings remains unclear. Stakeholders and shareholders alike are advised that the outcomes of these proceedings are highly uncertain. The management team, along with legal and financial advisors, will be assessing the situation and looking for viable options moving forward.

About Affimed N.V.

Affimed N.V. operates in the field of immuno-oncology, focusing on harnessing the power of the innate immune system to develop innovative cancer therapies. The company's proprietary innate cell engagers (ICE) are designed to target and eliminate solid tumors and hematologic malignancies, aiming to restore patients’ innate abilities to combat cancer effectively.

Innovative Approaches in Cancer Treatment

Using its ROCK platform, Affimed has been able to generate tailored molecules that engage the body's immune response specifically to attack cancer cells. Several of these ICE candidates are currently undergoing clinical trials, potentially offering new hope to patients battling various forms of cancer.

Investor and Media Relations

The company remains in touch with its investors, and communications are ongoing as the situation develops. Key contacts for investor relations include Alexander Fudukidis, who serves as the Director of Investor Relations. He is available via email for queries and updates.

For media inquiries, Mary Beth Sandin is the point of contact, handling communications regarding the company's public messaging and media relations.

Frequently Asked Questions

What led to Affimed's decision to file for insolvency?

Affimed's filing for insolvency was necessitated by ongoing challenges in securing adequate funding to continue operations.

What are the implications of the insolvency filing?

The filing may lead to the suspension of the company’s shares from trading and potential delisting from Nasdaq.

How does Affimed's technology work?

Affimed utilizes innate cell engagers (ICE) to target and eliminate cancer cells by leveraging the body's immune response.

Who can investors contact for more information?

Investors can reach out to Alexander Fudukidis, Director of Investor Relations, for updates and inquiries.

What happens next for Affimed?

The company will navigate through the insolvency proceedings while exploring options that could lead to resolution and potential recovery.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Christian Faith: Navigating Spiritual Pitfalls Wisely

Updated Category News Views 126

Taking a Deep Look at Christian Faith If you think faith is as simple as saying a few prayers and checking church attendance off the list, well, think again. G. Joseph Johnson, in his thought-provoking tome "Roads, Ditches, Traps, and Snares," believes that faith is a journey filled with twists, turns, and yes, a few traps. This book is a sort of roadmap for Christians,...

Continue Reading
Net Zero Efforts to Cost Europe €60B Annually by 2050

Updated Category News Views 139

Hefty Prices Loom Over Net Zero Commitments Well, strap in for a wallet buster, folks. Europe's largest players are staring down the barrel of a colossal €60 billion annual bill to clean up their carbon mess by 2050. That's the ticker in Senken's latest report, 'Pace of Change 2026.' Talks like these remind me there's no such thing as a free lunch, especially when...

Continue Reading
YYForce's Strategic Play: Robotics and AI Expansion

Updated Category News Views 78

Innovation Meets Pragmatism at YYForce There's a new bout of excitement brewing over at YYForce Inc. (NASDAQ: YFOR), if the latest announcements are anything to go by. The Singapore-based AI-enabled workforce dynamo is laying out priorities like a general plotting a campaign—pragmatic, strategic, and with a keen eye on the bottom line. Aiming for a Technological Edge In...

Continue Reading
Caladan Partners with Anchorage for Stronger Trading

Updated Category News Views 75

Caladan and Anchorage Unite for Asset Growth Man, partnerships might just be the secret sauce we never know we need until it’s on our plate. It's a fresh day in digital trading, and Caladan just shook things up by teaming up with Anchorage Digital, bolstering their trading and settlement capabilities to satisfy the big players. If there's one thing that's hot as a...

Continue Reading
DHL Leverages Robust Growth in Resilient Supply Chains

Updated Category News Views 88

Supply Chain Resilience: A Strategic Game Changer Market volatility's got its teeth in the game, and everyone in logistics knows it. DHL Supply Chain isn't just sitting back; they're riding the wave of change, snagging a 12% revenue bump in 2026. It's not your typical headline growth, either. More like the kind of growth that gets logistics gurus eyeing those contract...

Continue Reading
Guangdong-US Trade: LED Screens, Beef & Trust Make Waves

Updated Category News Views 81

Guangdong's Economic Ballet with the U.S. Grab a cup of coffee, and let's unravel how Guangdong and the U.S. are tangoing their way through trade like nobody's business! Guangdong, the heavyweight champ for U.S.-China trade transactions, notched up a cool 685.27 billion yuan ($102 billion) in the first eight months of 2026. That's a healthy jump of 6.9% year on year, mind...

Continue Reading
Radiate Holdco's Q3 Results: What We Know Now

Updated Category News Views 44

Digging Into Third Quarter Highlights Radiate Holdco, LLC has just thrown its third-quarter financial hat into the ring, stirring up some interest in the world of FLFO secured notes and senior notes. The folks in Princeton, N.J., sure know how to keep things exclusive—this intel is only for those holding their Notes or in the pretty exclusive club of qualified...

Continue Reading
AI Alliance Rethinks Health Plan Engagement

Updated Category News Views 107

Building Bridges in Healthcare Ever seen healthcare stuck in its own muck with disconnected gears attempting to move the same machine? Well, that's precisely the mountain healthplans.ai and URAWARRIOR aim to climb down from. Founders Rachel Spilo and Dr. Bershan Shaw are gearing up to shake hands in their no-nonsense, real-world vow to sync member engagement with the...

Continue Reading
Exploring Why Dead Outlets Stay Dead: Expert Insights

Updated Category News Views 86

The Mystery of Non-Responsive Outlets Ever found an electrical outlet refusing to cooperate when you need it most? Well, I know the frustration all too well. You'd think if the breaker ain't blown, the outlet should work like a charm. But dive into the guts of the story, and you find a series of surprises waiting to trip us up. Common Culprits: Tripped GFCIs and Loose...

Continue Reading
Epic Legal Battle Yields $63M Verdict Against Chevron

Updated Category News Views 147

A David vs. Goliath Showdown in Court How's this for a courtroom drama? Picture eight lawyers taking on Chevron over a toxic pit buried beneath an unsuspecting family's home. These folks at Ernst Law Group and Trial Lawyers for Justice tackled Union Oil (now Chevron) and bagged a staggering $63 million for their client. This ain't your run-of-the-mill legal squabble; it's...

Continue Reading

Top 5 Most Recently Viewed Articles

Nulogy and Kinaxis Team Up to Transform Supply Chain Dynamics

Updated Category News Views 125

Strategic Alliance Between Nulogy and Kinaxis Nulogy and Kinaxis have formed a significant partnership aimed at improving synchronization within manufacturing supply chain networks. Together, they plan to deliver innovative solutions that will streamline operations for the fast-moving consumer goods (FMCG) and life sciences sectors. Enhancing Collaboration in Supply Chain...

Continue Reading
EssentiallySports Welcomes Natasha Howard as New Correspondent

Updated Category News Views 317

EssentiallySports Welcomes Natasha Howard as New Correspondent Indiana Fever Star to Serve as Athlete Correspondent, Providing Exclusive Behind-the-Scenes Access EssentiallySports, a leading sports media publisher, has forged an exciting partnership with three-time WNBA champion Natasha Howard, known for her outstanding performances with the Indiana Fever. Howard’s new...

Continue Reading
Sinch Unveils Innovative RCS Business Service for Telcos

Updated Category News Views 194

Sinch's Cutting-Edge RCS Business Enablement Service Sinch is leading the way in transforming communication for businesses with its latest offering: the RCS Business Enablement service. This service aims to streamline RCS operations, enhancing monetization and simplifying financial management for telecom operators. As the mobile messaging landscape evolves, enterprises...

Continue Reading
Viking Therapeutics Reveals Promising Results for VK2735 in Obesity

Updated Category News Views 201

Viking Therapeutics Announces Breakthrough Findings in Obesity Treatment Viking Therapeutics, Inc. recently shared impressive news regarding the results from their Phase 2 clinical trial of VK2735, a dual agonist designed to tackle obesity. Ensuring patients can combat weight-related issues is a growing concern, and VK2735’s performance offers a beacon of hope....

Continue Reading
Elev8 Corporate Finance Announces Innovative Flat-Fee Model

Updated Category News Views 242

Elev8 Revolutionizes Bridge Financing for Businesses Elev8 Corporate Finance, a prominent private credit advisor, has unveiled an innovative compensation model aimed at empowering lower-middle-market businesses. This new flat-fee plus exit strategy unlike traditional broker commissions, promises a quicker and more cost-effective solution for securing bridge capital....

Continue Reading